The information highlighted (if any) are the most recent updates for this brand.
Xultophy is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control, and the populations studied, see Precautions, Interactions and Pharmacology: Pharmacodynamics under Actions.